Disclosures for "Is GBA1 Neuroprotective in Glia in Slowing Parkinson’s Disease Progression?"
-
Mr. Weiss has nothing to disclose.
-
Ms. Fish has nothing to disclose.
-
Mr. Khera has nothing to disclose.
-
Miss Park has nothing to disclose.
-
Ms. Estes has nothing to disclose.
-
Selina Yu has nothing to disclose.
-
Leo Pallanck has nothing to disclose.
-
The institution of Dr. Young has received research support from NIH. The institution of Dr. Young has received research support from BrightFocus Foundation. The institution of Dr. Young has received research support from Biogen.
-
The institution of Dr. Davis has received research support from NIH NINDS. The institution of Dr. Davis has received research support from University of Washington Institute for Stem Cell and Regenerative Medicine. The institution of Dr. Davis has received research support from VA BLRD. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a study section grant reviewer with NIH. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with Parkinson's Foundation.